1. US Food and Drug Administration . Exposure Modification Modified Risk Granted Orders, FDA submission tracking numbers (STNs): MR0000059-MR0000061, MR0000133, 2020. Available: https://www.fda.gov/media/139797/download [Accessed 6 Aug 2020].
2. Philip Morris Products S.A. MRTPA - Section 2.7 Executive Summary. Available: https://www.fda.gov/media/105437/download [Accessed 16 Oct 2020].
3. Philip Morris International . Philip Morris International Announces U.S. Food and Drug Administration Authorization for Sale of IQOS in the United States. Available: https://www.pmi.com/media-center/press-releases/press-details/?newsId=15596 [Accessed 16 Oct 2020].
4. Times of Malta . Philip Morris receives FDA authorisation to market IQOS in US, 2020. Available: https://timesofmalta.com/articles/view/philip-morris-receives-fda-authorisation-to-market-iqos-in-us.811917 [Accessed 10 Oct 2020].
5. Leyco CS , Bulletin M . Philip Morris urges PH to adopt US FDA finding, 2020. Available: https://mb.com.ph/2020/09/07/philip-morris-urges-ph-to-adopt-us-fda-finding/ [Accessed 10 Oct 2020].